Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
NK2-H82E3 | Human | Biotinylated Human IL-12B / NKSF2 / p40 Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
NK2-M82E5 | Mouse | Biotinylated Mouse IL-12B / NKSF2 / p40 Protein, His,Avitag™ (MALS verified) | ![]() |
![]() ![]() |
![]() ![]() |
NK2-H5258 | Human | Human IL-12B / NKSF2 / p40 Protein, Fc Tag | ![]() |
![]() ![]() |
![]() ![]() |
NK2-H52H7 | Human | Human IL-12B / NKSF2 / p40 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() ![]() ![]() |
Loaded Human IL-12 R beta 1, Fc Tag (Cat. No. ILB-H5255) on Protein A Biosensor, can bind Human IL-12B, His Tag (Cat. No. NK2-H52H7) with an affinity constant of 3.78 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Ustekinumab | CNTO-1275; C-340; AVT-04 | Approved | Janssen Global Services Llc | Stelara | Mainland China | Plaque psoriasis | Janssen-Cilag International Nv | 2009-01-15 | Multiple Sclerosis; Dermatitis, Atopic; Plaque psoriasis; Crohn Disease; Uveitis; Common Variable Immunodeficiency; Hidradenitis Suppurativa; Colitis, Ulcerative; Arthritis, Psoriatic; Takayasu Arteritis; Lupus Erythematosus, Systemic; Psoriasis; Diabetes Mellitus, Type 1; Arthritis, Juvenile; Sjogren's Syndrome; Spondylitis, Ankylosing; Ichthyosis; Pouchitis; Inflammatory Bowel Diseases; Dermatomyositis; Type I Leukocyte Adhesion Defect; Polymyositis; Liver Cirrhosis, Biliary | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
SAR-441000 | SAR441000; SAR-441000; BNT-131 | Phase 1 Clinical | Biontech Se, Sanofi | Neoplasm Metastasis | Details |
Ebdarokimab | AK-101 | Phase 3 Clinical | Zhongshan Akeso Biopharma Co Ltd | Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic; Crohn Disease; Plaque psoriasis | Details |
Ustekinumab biosimilar(Amgen) | ABP-654 | Phase 3 Clinical | Amgen Inc | Solid tumours; Psoriasis | Details |
This web search service is supported by Google Inc.